In particular, overexpression and amplification of the EGFR is present in 80–100% of squamous cell carcinomas of the head and neck and portends poor prognosis, inferior survival, radioresistance, and treatment failures [3], [6]. Here, EGFR is linked to squamous cell carcinoma.